文献速递头颈部肿瘤放疗姑息放疗与转移瘤

HOPON(高压氧预防放射性骨坏死):高压氧预防头颈部放疗后下颌骨牙槽手术后放射性骨坏死的随机对照试验

HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): A Randomized Controlled Trial of Hyperbaric Oxygen to Prevent Osteoradionecrosis of the Irradiated Mandible After Dentoalveolar Surgery.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2019-03-07

HOPON 是一项随机对照3期试验,纳入既往放疗>50 Gy后需下颌牙拔除或种植的患者144例,按1:1随机接受或不接受高压氧(HBO),所有患者均用氯己定漱口液和抗生素;主要终点为术后6个月放射性骨坏死(ORN),可分析100例,HBO组与对照组ORN发生率分别为6.4%与5.7%(OR 1.13,95%CI 0.14-8.92,P=1);作者结论认为ORN发生率低,推荐HBO用于放疗后下颌牙拔除或种植已无必要,该结果与近期Cochrane综述及既往报告非HBO组ORN发生率14%至30%的试验相反,并挑战长期确立的诊疗标准。

要点

  • HBO组与对照组术后6个月ORN发生率分别为6.4%与5.7%(OR 1.13,95%CI 0.14-8.92,P=1)。
  • HBO组急性症状较少,但晚期疼痛或生活质量无显著差异。
  • 作者结论认为ORN发生率低,推荐HBO用于放疗后下颌牙拔除或种植已无必要。

核心结论

  • 作者结论认为ORN发生率低,推荐HBO用于放疗后下颌牙拔除或种植已无必要。
  • 作者指出该结果与近期发表的Cochrane综述及既往报告非HBO组ORN发生率14%至30%的试验相反,并挑战长期确立的诊疗标准。

研究设计与样本

  • HOPON为随机对照3期试验,纳入既往放疗>50 Gy后需下颌牙拔除或种植的患者。
  • 符合条件患者按1:1随机分配接受或不接受HBO,所有患者均接受氯己定漱口液和抗生素。
  • HBO组患者在2.4个绝对大气压下每日潜水30次、每次100%氧气80至90分钟。
  • 共144例患者随机化,其中100例纳入主要终点分析。
  • 主要终点为术后6个月ORN诊断,由盲法中心审查临床照片和X线片确定。

主要发现

  • 术后6个月ORN发生率HBO组为6.4%,对照组为5.7%(OR 1.13,95%CI 0.14-8.92,P=1)。
  • HBO组急性症状较少,但晚期疼痛或生活质量无显著差异。
  • HBO组脱落率较高,但完成试验的两组基线特征相当。

局限性

  • HBO组脱落率较高。
  • 作者结论指出该结果与近期Cochrane综述及既往试验相反,并挑战长期确立的诊疗标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Hyperbaric oxygen (HBO) has been advocated in the prevention and treatment of osteoradionecrosis (ORN) of the jaw after head and neck radiation therapy, but supporting evidence is weak. The aim of this randomized trial was to establish the benefit of HBO in the prevention of ORN after high-risk surgical procedures to the irradiated mandible. METHODS AND MATERIALS: HOPON was a randomized, controlled, phase 3 trial. Participants who required dental extractions or implant placement in the mandible with prior radiation therapy >50 Gy were recruited. Eligible patients were randomly assigned 1:1 to receive or not receive HBO. All patients received chlorhexidine mouthwash and antibiotics. For patients in the HBO arm, oxygen was administered in 30 daily dives at 100% oxygen to a pressure of 2.4 atmospheres absolute for 80 to 90 minutes. The primary outcome measure was the diagnosis of ORN 6 months after surgery, as determined by a blinded central review of clinical photographs and radiographs. The secondary endpoints included grade of ORN, ORN at other time points, acute symptoms, pain, and quality of life. RESULTS: A total of 144 patients were randomized, and data from 100 patients were analyzed for the primary endpoint. The incidence of ORN at 6 months was 6.4% and 5.7% for the HBO and control groups, respectively (odds ratio, 1.13; 95% confidence interval, 0.14-8.92; P = 1). Patients in the hyperbaric arm had fewer acute symptoms but no significant differences in late pain or quality of life. Dropout was higher in the HBO arm, but the baseline characteristics of the groups that completed the trial were comparable between the 2 arms. CONCLUSIONS: The low incidence of ORN makes recommending HBO for dental extractions or implant placement in the irradiated mandible unnecessary. These findings are in contrast with a recently published Cochrane review and previous trials reporting rates of ORN (non-HBO) of 14% to 30% and challenge a long-established standard of care.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Shaw RJ, Butterworth CJ, Silcocks P, et al. HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): A Randomized Controlled Trial of Hyperbaric Oxygen to Prevent Osteoradionecrosis of the Irradiated Mandible After Dentoalveolar Surgery. Int J Radiat Oncol Biol Phys. 2019. PMID: 30851351. doi:10.1016/j.ijrobp.2019.02.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。